Results 161 to 170 of about 21,624 (243)

A bidirectional 2-sample Mendelian randomization study of depressed mood and premature ovarian insufficiency. [PDF]

Medicine (Baltimore)
Chen K, Wan L, Wang X, Ma X, Chen Y, Han L.   +5 more
europepmc   +1 more source

Nanomotor‐Driven Extracellular Vesicles With Effective Tissue Penetration for Targeted Therapy of Primary Ovarian Insufficiency

Journal of Extracellular Vesicles, Volume 15, Issue 3, March 2026.
ABSTRACT Stem cells and their derived extracellular vesicles (EVs) offer hope for functional reconstruction and fertility in premature ovarian insufficiency (POI) caused by gonadotoxic drugs. However, the clinical application of EVs is impeded by their instability, limited tissue penetration, and lack of targeted delivery to ovarian injury sites. Here,
Yaoqin Mu, Jiachen Wu, Mingwei Lv, Xinyi Zhang, Yinhua Song, Jihui Ai, Ding Ma, Kezhen Li   +7 more
wiley   +1 more source

Diagnostic challenges in suspected premature ovarian insufficiency

Case Reports in Women's Health, 2022
Eleni Armeni
doaj   +1 more source

Mesenchymal stem cell therapy for premature ovarian insufficiency: progress and challenges. [PDF]

J Ovarian Res
Shao Z, Liang L, Xue Y, Zhu T, Wen Q.
europepmc   +1 more source

International Contrast Ultrasound Society Safety Round Table

Journal of Ultrasound in Medicine, Volume 45, Issue 3, Page 473-485, March 2026.
The international Contract Ultrasound Society (ICUS) held a round table discussion on the safety of ultrasound contrast agents for cardiology, radiology, and pediatrics on September 4, 2024. The panel included international experts on ultrasound contrast.
Richard G. Barr, Jordan Strom, Dirk A. Clevert, Stephanie R Wilson, Thomas Porter, Kassa Darge   +5 more
wiley   +1 more source

Unveiling mitochondrial and PANoptosis-related biomarkers for premature ovarian insufficiency. [PDF]

J Ovarian Res
Ma Z, Sun H.
europepmc   +1 more source

Targeting Tumor Dormancy and Recurrence: Molecular Mechanisms and Peptide Therapeutic Delivery

MedComm – Oncology, Volume 5, Issue 1, March 2026.
This review summarizes the molecular mechanisms that regulate tumor dormancy and its role in cancer recurrence, with emphasis on immune evasion, extracellular matrix remodeling, metabolic regulation and angiogenic switching. It further discusses emerging peptide–based therapeutic strategies aimed at detecting, modulating, and eliminating dormant tumor ...
Abdur Raheem Aleem, Atif Ali, Wajid Ali, Yuying Cheng, Zhibin Yan, Chaoyi Xia, Chenguang Liu, Caiyun Fu, Yiren Hu, Xi Wang   +9 more
wiley   +1 more source

Pathogenic mechanisms and therapeutic potential of the microbiome in premature ovarian insufficiency. [PDF]

Front Immunol
Ma S, Zheng L, Zhuang X, Wang M, Zou Y.
europepmc   +1 more source

Aging‐Derived Alterations in Genomic, Immune, and Metabolic Networks: Implications for Cancer Development and Therapy

MedComm – Oncology, Volume 5, Issue 1, March 2026.
Ageing acts as a double‐edged sword in cancer. In the elderly, open chromatin, immunosenescence, and chronic inflammation drive SASP (IL‐6, MMPs), MDSC accumulation and T‐cell suppression, fostering tumor‐promoting microenvironments and limited therapeutic benefit.
Qi Wang, Xue Sun, Xinhao Han, Xingda Zhang, Wenzheng Wang, Hongbin Wang, He Ren, Lina Gu   +7 more
wiley   +1 more source

Novel variants associated with premature ovarian insufficiency in Russian adolescents. [PDF]

Front Endocrinol (Lausanne)
Tsabai P, Kumykova Z, Averkova V, Pavlova N, Maslennikov D, Bolshakova A, Batyrova Z, Kolpakova T, Bystritskiy A, Karetnikova N, Ekimov A, Goltsov A, Kuznetsova M, Turchinets A, Mukosey I, Kochetkova T, Sadelov I, Shubina J, Uvarova E, Yureneva S, Trofimov D, Sukhikh G.   +21 more
europepmc   +1 more source